Safety & Tolerability

Ranexa has an established safety profile, including safety data in special patient populations.

Established Safety Profile

View contraindications, warnings and precautions, adverse events, electrocardiographic data, and drug interaction information.

Safety Profile in Special Patient Populations

Ranexa has been studied in chronic angina patients including patients with diabetes, heart failure and renal impairment, as well as geriatric patients.

Holter Safety Data

Over 1 million hours of Holter data collected from more than 6000 patients in a placebo-controlled study.³

Learn more

Was this page helpful?

You are now leaving Ranexa.com.

You are now leaving the Ranexa website. Gilead Sciences, Inc. provides these links as a convenience; however, Gilead does not control, review, or endorse third-party websites, and is not responsible for the content of the website you are about to enter.

Share this page

Fill out the fields below to send this Web page to a colleague.

* required item